Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme for Sinusitis in Cystic Fibrosis
NCT00416182Phase 2Completed
- Sponsor
- The University of Vermont
- Start
- Dec 2006
- Primary completion
- Jun 2012
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dornase alfa in sinusitis, sponsored by The University of Vermont. Started Dec 2006; status: completed.
02
Drugs
dornase alfa
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT00416182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416182.